Phenomic AI
Targeting disease micro-environments in cancer and fibrosis by using a combination of automated microscopy, single cell sequencing, and machine learning.
Launch date
Employees
Market cap
-
Enterprise valuation
€33—49m (Dealroom.co estimates Nov 2023.)
Toronto Ontario (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | Grant | |
$2.0m | Seed | ||
| N/A | N/A | - | |
* | $6.0m | Seed | |
* | $9.0m | Early VC | |
| Total Funding | €15.5m | ||
Related Content
Recent News about Phenomic AI
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.